Trademark Overview
On Thursday, March 7, 2024, a trademark application was filed for CIATRIX with the United States Patent and Trademark Office. The USPTO has given the CIATRIX trademark a serial number of 98439171. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, January 13, 2025. This trademark is owned by CIATRIX, Inc.. The CIATRIX trademark is filed in the Medical Instrument Products category with the following description:
medical devices for use in treating neurodegenerative diseases, neurocognitive diseases, Alzheimer’s disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; therapeutic devices using cerebrospinal fluid motion, cerebrospinal fluid pressure changes, spinal motion, and respiratory inhalation and exhalation to improve performance of lymphatic system, performance of glymphatic system, posture, glymphatic clearance, drug delivery in cerebrospinal fluid, and drug delivery in blood and to lower brain wave activity to provide relief from neurodegenerative diseases, neurocognitive diseases, Alzheimer’s disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; diagnostic devices, namely, medical diagnostic apparatus for testing cerebrospinal fluid dynamics
